MedTrace Logo

EndoVascular Aortic Dissection Early vs Delayed

NCT07143071 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 4068

Last updated 2025-08-27

No results posted yet for this study

Summary

This is a prospective, multicenter, non-inferior, parallel-controlled observational study. This study aims to compare clinical outcomes of endovascular treatment for acute high-risk type B aortic dissection in the acute phase versus the subacute phase. No interventions will be imposed on the patients' standard treatment. Patients with acute high-risk type B aortic dissection will be grouped based on the actual timing of their treatment.

Conditions

  • Aortic Dissection Type B

Interventions

PROCEDURE

Acute Phase

Patients with acute high-risk type B aortic dissection received endovascular treatment in acute phase (2-14days)

PROCEDURE

Subacute Phase

Patients with acute high-risk type B aortic dissection received endovascular treatment in subacute phase (≥14days)

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2028-07-31
Completion
2030-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07143071 on ClinicalTrials.gov